Page 4 - Multiple Sclerosis Ms News Today

People with multiple sclerosis and moderate-to-severe walking disability could engage in physical activity and improve their physical function with an adapted running frame, suggests new research.

A smartwatch and sophisticated artificial intelligence to analyze data could open a new frontier in monitoring disease progression, researchers say.

People with multiple sclerosis and obesity can achieve substantial weight loss, leading to improved mobility and quality of life, with a specially designed program, new trial results suggest.

Clinicians prescribing a drug for patients with multiple sclerosis who are on multiple treatments may in future use AI to identify potential interactions and suggest safer options, new data suggest.

The relapse benefit of ocrelizumab in multiple sclerosis is confirmed for the first time in patients 60 and older starting therapy, say researchers in findings they hope will inform choices.

Internet-based cognitive behavioral therapy significantly reduces depressive symptoms in patients with MS, results from a multisite, phase 3, randomized trial show.

XR-BUP allows more time to access follow-up care in patients with opioid overdose.

73% of patients with relapsing remitting multiple sclerosis were disease free 5 years after aHSCT treatment, and more than half reported improved disability.

Scientists aim to use a new vaccine to treat autoimmune diseases like MS, Type 1 diabetes, asthma, and Crohn's disease.

The ingredient found in Sudafed PE and Vicks Sinex is no better than a placebo.